Definition of the Mamu A*01 Peptide Binding Specificity: Application to the Identification of Wild-Type and Optimized Ligands from Simian Immunodeficiency Virus Regulatory Proteins
- 1 December 2000
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 165 (11) , 6387-6399
- https://doi.org/10.4049/jimmunol.165.11.6387
Abstract
Single amino acid substitution analogs of the known Mamu A*01 binding peptide gag 181-190 and libraries of naturally occurring sequences of viral or bacterial origin were used to rigorously define the peptide binding motif associated with Mamu A*01 molecules. The presence of S or T in position 2, P in position 3, and hydrophobic or aromatic residues at the C terminus is associated with optimal binding capacity. At each of these positions, additional residues are also tolerated but associated with significant decreases in binding capacity. The presence of at least two preferred and one tolerated residues at the three anchor positions is necessary for good Mamu A*01 binding; optimal ligand size is 8–9 residues. This detailed motif has been used to map potential epitopes from SIVmac239 regulatory proteins and to engineer peptides with increased binding capacity. A total of 13 wild type and 17 analog candidate epitopes were identified. Furthermore, our analysis reveals a significantly lower than expected frequency of epitopes in early regulatory proteins, suggesting a possible evolutionary- and/or immunoselection directed against variants of viral products that contain CTL epitopes.Keywords
This publication has 51 references indexed in Scilit:
- Tackling tatJournal of Molecular Biology, 1999
- Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions.Journal of Clinical Investigation, 1998
- Two complementary methods for predicting peptides binding major histocompatibility complex moleculesJournal of Molecular Biology, 1997
- HIV-1, Vpr and the cell cycleCurrent Biology, 1996
- Three regions of HIV-1 gp160 contain clusters of immunodominant CTL epitopesImmunology Letters, 1996
- Evidence that a Single Peptide–MHC Complex on a Target Cell Can Elicit a Cytolytic T Cell ResponseImmunity, 1996
- Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA moleculesHuman Immunology, 1996
- Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 moleculesCell, 1993
- HLA-A11 Epitope Loss Isolates of Epstein-Barr Virus From a Highly A11 + PopulationScience, 1993
- A Comparison of Regulatory Features in Primate LentivirusesAIDS Research and Human Retroviruses, 1992